Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis drops PhII Parkinson's program

Oct 23 2013

• By Eleanor Malone

Related Companies

PsychoGenics Inc.

Novartis AG

Merz Pharmaceuticals GmbH

Avanir Pharmaceuticals, Inc.

Addex Therapeutics Ltd

Additional Topics

Orthopedics Neurology

More from Musculoskeletal

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window